Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Atavistik Bio, Inc
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
Bayer
Convalife (Shanghai) Co., Ltd.
Eli Lilly and Company
ViroMissile, Inc.
Arcus Biosciences, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
AstraZeneca
Tizona Therapeutics, Inc
Normunity AccelCo, Inc.
Eli Lilly and Company
MacroGenics
SystImmune Inc.
Daiichi Sankyo
Eli Lilly and Company
Adela, Inc
Orano Med LLC
Radiopharm Theranostics, Ltd
Eli Lilly and Company
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Innate Pharma
OncoNano Medicine, Inc.
Risen (Suzhou) Pharma Tech Co., Ltd.
Tanabe Pharma America, Inc.
Massive Bio, Inc.
Rondo Therapeutics
Actym Therapeutics, Inc.
LigaChem Biosciences, Inc.
Travera Inc
Nurix Therapeutics, Inc.
Adcentrx Therapeutics
Incyte Corporation
Merck Sharp & Dohme LLC
Medicenna Therapeutics, Inc.
AstraZeneca
NextPoint Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Klus Pharma Inc.
Tempus AI
Exelixis
Pfizer
Cofactor Genomics, Inc.
Singlera Genomics Inc.
Seagen Inc.
RAPT Therapeutics, Inc.